NCT01267032

Brief Summary

This project is designed to determine whether an efficacious behavioral intervention for insomnia can improve the quit rates achieved by an efficacious smoking cessation program aimed at PTSD patients ("Integrated Care"). A second aim is to deepen our understanding of the mechanisms relating sleep and smoking in PTSD.

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
142

participants targeted

Target at P75+ for phase_2

Timeline
Completed

Started Oct 2011

Geographic Reach
1 country

1 active site

Status
terminated

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

December 23, 2010

Completed
1 day until next milestone

First Posted

Study publicly available on registry

December 24, 2010

Completed
9 months until next milestone

Study Start

First participant enrolled

October 1, 2011

Completed
1.7 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 1, 2013

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

June 1, 2013

Completed
Last Updated

December 2, 2014

Status Verified

December 1, 2014

Enrollment Period

1.7 years

First QC Date

December 23, 2010

Last Update Submit

December 1, 2014

Conditions

Outcome Measures

Primary Outcomes (1)

  • seven-day point prevalence abstinence

    21 days post-quit-day

Study Arms (2)

Arm 1

EXPERIMENTAL

Integrated Care + Cognitive-Behavioral Treatment for Insomnia

Behavioral: Integrated CareBehavioral: Cognitive-Behavioral Treatment for Insomnia

Arm 2

SHAM COMPARATOR

Integrated Care + Desensitization Treatment for Insomnia

Behavioral: Integrated CareBehavioral: Desensitization Treatment for Insomnia

Interventions

Integrated CareBEHAVIORAL

A PTSD-aware smoking cessation intervention developed by Miles McFall, PhD.

Arm 1Arm 2

A behavioral treatment aimed at improving sleep continuity and subjective sleep through stimulus control, sleep restriction, and attenuation of maladaptive sleep-related cognitions.

Arm 1

A credible sham treatment for insomnia matching CBTI in treatment time, patient expectations, therapist expectations, etc.

Arm 2

Eligibility Criteria

Age18 Years - 65 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Potential participants will be smokers who have smoked at least 10 cigarettes per day for the past year,
  • are motivated to make a smoking cessation attempt,
  • are na ve to behavioral sleep treatment and are willing to be randomly assigned to either one of the sleep treatment arms.
  • Participants must meet the criteria for PTSD and or partial PTSD.
  • They will indicate a willingness to forgo the use of all alternative tobacco products during their attempt to quit cigarettes.
  • They will be fluent in English.

You may not qualify if:

  • Candidates who meet DSM-IV criteria for schizophrenia,
  • current manic syndrome,
  • lifetime but not current PTSD or partial PTSD,
  • or current substance abuse/dependence will be excluded.
  • subjects reporting a prior diagnosis of severe obstructive sleep apnea will be excluded unless they have been successfully treated via weight loss, surgery, or continuous positive airway pressure to which they are reliably adherent.
  • We expect these criteria to exclude 15 to 20% of potential participants.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

VA Palo Alto Health Care System, Palo Alto, CA

Palo Alto, California, 94304-1290, United States

Location

MeSH Terms

Conditions

Smoking

Interventions

Delivery of Health Care, IntegratedDesensitization, Immunologic

Condition Hierarchy (Ancestors)

Behavior

Intervention Hierarchy (Ancestors)

Delivery of Health CarePatient Care ManagementHealth Services AdministrationHealth Care Quality, Access, and EvaluationImmunosuppression TherapyImmunotherapyImmunomodulationBiological TherapyTherapeuticsImmunologic TechniquesInvestigative Techniques

Study Officials

  • Steven H. Woodward, PhD

    VA Palo Alto Health Care System, Palo Alto, CA

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
phase 2
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
FED
Responsible Party
SPONSOR

Study Record Dates

First Submitted

December 23, 2010

First Posted

December 24, 2010

Study Start

October 1, 2011

Primary Completion

June 1, 2013

Study Completion

June 1, 2013

Last Updated

December 2, 2014

Record last verified: 2014-12

Locations